专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明专利

GB141954A An improved riddle 未知
公开(公告)号：GB141954A
公开(公告)日：1920-04-29
申请号：GB1382319
申请日：1919-05-31
申请人： JOHN KANE MCDONALD
IPC分类号： B07B1/48
摘要： 141,954. McDonald, J. K. May 31, 1919. Hand sieves.-In a hand sieve, the woven wire, cloth, or other screening- material 1 is fastened between an inner wooden hoop 2 and the usual outer hoop 3, the hoop and frame being secured together by binding- wire, nails, screws, or the like 5. The edge of the wire cloth may be provided with a wire hoop or binding 4, and the cloth may be supported by diagonal cross wires 6 which mav serve to clinch the hoop and the frame together.

2. 发明专利

GB201800711D0 Multiproduct aerosol convertor/attachment 未知
公开(公告)号：GB201800711D0
公开(公告)日：2018-02-28
申请号：GB201800711
申请日：2018-01-16
申请人： WELSH JOHN KANE

3. 发明专利

AP00901S1 SELF-SERVICE BIOMETRIC KIOSK 未知
公开(公告)号：AP00901S1
公开(公告)日：2017-05-02
申请号：AP2016001135
申请日：2016-08-10
申请人： VATOSCAN PTY LTD , KININMONTH JOHN KANE , MULLER RAFI LEIGH
发明人： KANE JOHN KININMONTH , LEIGH RAFI MULLER

4. 发明专利

PH27331A Dual-action tablet 未知
公开(公告)号：PH27331A
公开(公告)日：1993-06-08
申请号：PH40068
申请日：1990-02-19
申请人： RICHARD JOHN DANSEREAU , MICHAEL JOHN KANE
发明人： DANSEREAU RICHARD JOHN , KANE MICHAEL JOHN
IPC分类号： A61K31/09 , A61K9/24 , A61K31/135 , A61K47/32 , A61K47/38 , A61P9/04
摘要： The present invention provides a dual-action tablet composition comprising: (a) an outer tablet comprising a first dose of active ingredient dispersed in a pH independent hydrophilic polymer matrix; and (b) an inner tablet comprising a second dose of active ingredient in a rapidly disintegrating excipient base. This dual-action tablet is especially efficacious for those active ingredients which half lives of less than two hours and which experience decreased absorption efficiency in the lower gastrointestinal tract. Among the preferred dual-action tablet composition is one wherein the active ingredient in both the inner and outer tablets is guaifenesin. Upon administration, the outer tablet provides a controlled release of the active ingredient while the inner tablet gives a second dose of active ingredient after the outer tablet has partially dissolved.

5. 发明授权

US10313191B2 System and method for managing virtual local area networks 有权
公开(公告)号：US10313191B2
公开(公告)日：2019-06-04
申请号：US11849010
申请日：2007-08-31
申请人： James Ryan , Marcus Hadavi , Mike Renner , Raoul Alcala , John Kane , Hans Zeschin , Roberte Faber
发明人： James Ryan , Marcus Hadavi , Mike Renner , Raoul Alcala , John Kane , Hans Zeschin , Pete Faber
IPC分类号： H04L12/56 , H04L12/24 , H04L12/46
摘要： A method for identifying VLANs associated with a network includes gathering actual network element configuration data from a plurality of network elements in the network, wherein the actual network element configuration data identifies one or more VLANs that at least some of the plurality of network elements are actually allocated to; correlating the actual network element configuration data with administrative VLAN data; and determining one or more VLANs that are not commonly identified in both the actual network element configuration data and the administrative VLAN data. A system includes a network monitoring system operable to gather actual network element configuration data from a plurality of network elements at one or more logical network sites, wherein the actual network element configuration data identifies one or more VLANs that at least some of the plurality of network elements are actually allocated to; and a VLAN services module operable to correlate the actual network element configuration data with administrative VLAN data, and further operable to determine one or more VLANs that are not commonly identified in both the actual network element configuration data and the administrative VLAN data.

6. 发明申请

US20130245965A1 Handheld HVAC/R Test and Measurement Instrument 审中-公开
标题翻译：手持式HVAC / R测试和测量仪器
公开(公告)号：US20130245965A1
公开(公告)日：2013-09-19
申请号：US13875683
申请日：2013-05-02
申请人： Michael John Kane , David Lauren Wheaton , Sean Patrick Tierney
发明人： Michael John Kane , David Lauren Wheaton , Sean Patrick Tierney
IPC分类号： G01D7/00
CPC分类号： G01D7/00 , F24F11/30 , F24F11/56 , F24F2110/00 , G05B23/0264 , G05B23/0272
摘要： A method of HVAC/R test and measurement using a plurality of test and measurement sensor heads, at least one power source and transmitter unit adapted to physically connect with any of the sensor heads and wirelessly transmit data to an external handheld-sized field use display and analysis instrument, including the steps of connecting the power source and transmitter unit a sensor head; performing a test and measurement by positioning the sensor head to sense and measure the desired parameter; transmitting data to the display and analysis instrument; and receiving the transmitted data on the display and analysis instrument. The display and analysis instrument may be connected to a sensor head, and preferably may receive wired or wirelessly transmitted test and measurement data from any number of communicably connected sensor heads. Wirelessly transmitted data may be received by another external display device such as a smartphone or similar computing device.
摘要翻译：一种使用多个测试和测量传感器头的HVAC / R测试和测量的方法，至少一个电源和发射器单元，其适于与任何传感器头物理连接并将数据无线地传输到外部手持式大小的现场使用显示器和分析仪器，包括连接电源和变送器单元传感器头的步骤; 通过定位传感器头来感测和测量所需参数来执行测试和测量; 向显示和分析仪器传输数据; 并在显示和分析仪器上接收发送的数据。显示和分析仪器可以连接到传感器头部，并且优选地可以从任何数量的可通信连接的传感器头部接收有线或无线传输的测试和测量数据。无线传输的数据可以由诸如智能电话或类似的计算设备的另外的外部显示设备接收。

7. 发明授权

US08475400B2 Osmotic devices and methods for diuretic therapy 失效
标题翻译：渗透装置和利尿剂治疗方法
公开(公告)号：US08475400B2
公开(公告)日：2013-07-02
申请号：US13346485
申请日：2012-01-09
申请人： Allan Charles Shuros , Eric A. Mokelke , Michael John Kane
发明人： Allan Charles Shuros , Eric A. Mokelke , Michael John Kane
IPC分类号： A61M37/00 , A61M31/00
CPC分类号： A61B17/1219 , A61B17/12031 , A61B17/12036 , A61B17/12099 , A61B17/12136 , A61F2250/0003
摘要： Embodiments of the invention are related to devices and methods for modulating renal function, amongst other things. In an embodiment, the invention includes a method of modulating renal function in a patient including implanting an occlusive device in the patient, the occlusive device comprising a semi-permeable membrane and configured to expand or contract based on the passage of a fluid across the semi-permeable membrane. Other aspects and embodiments are provided herein.
摘要翻译：本发明的实施方案涉及用于调节肾功能的装置和方法等。在一个实施方案中，本发明包括调节患者的肾功能的方法，包括在患者体内植入闭塞装置，所述闭塞装置包括半渗透膜，并且构造成基于穿过所述半透膜的流体通过而膨胀或收缩不渗透膜。本文提供了其它方面和实施例。

8. 发明申请

US20120322787A1 2-ACYLAMINOPROPOANOL-TYPE GLUCOSYLCERAMIDE SYNTHASE INHIBITORS 有权
标题翻译： 2-乙酰氨基酚类型葡萄糖苷合成酶抑制剂
公开(公告)号：US20120322787A1
公开(公告)日：2012-12-20
申请号：US13595349
申请日：2012-08-27
申请人： Craig Siegel , Cecilia M. Bastos , David J. Harris , Angeles Dios , Edward Lee , Richard Silva , Lisa M. Cuff , Mikaela Levine , Cassandra A. Celatka , Frederic Vinick , Thomas H. Jozefiak , Yibin Xiang , John Kane , Junkai Liao
发明人： Craig Siegel , Cecilia M. Bastos , David J. Harris , Angeles Dios , Edward Lee , Richard Silva , Lisa M. Cuff , Mikaela Levine , Cassandra A. Celatka , Frederic Vinick , Thomas H. Jozefiak , Yibin Xiang , John Kane , Junkai Liao
IPC分类号： A61K31/4025 , A61P3/10 , A61P13/12 , C07D409/14 , A61K31/4439 , A61K31/397 , A61K31/422 , C07D417/14 , A61K31/428 , A61K31/4245 , A61K31/444 , A61K31/5377 , C07D405/10 , C07D413/14
CPC分类号： C07D417/14 , C07D295/125 , C07D319/18 , C07D405/06 , C07D405/12 , C07D405/14 , C07D407/12 , C07D409/12 , C07D409/14 , C07D411/12 , C07D413/12 , C07D413/14
摘要： A compound is represented by Structural Formula (I): or a pharmaceutically acceptable salt thereof. A pharmaceutical composition comprises a compound represented by Structural Formula (I) or a pharmaceutically acceptable salt thereof. A method of treating a subject in need thereof comprises administering to the subject a therapeutically effective amount of a compound represented by Structural Formula (I) or a pharmaceutically acceptable salt thereof. The subject has type 2 diabetes; renal hypertrophy or hyperplasia associated with diabetic nephropathy; Tay-Sachs; Gaucher's; or Fabry's disease. Methods of decreasing plasma TNF-α, lowering blood glucose levels, decreasing glycated hemoglobin levels, inhibiting glucosylceramide synthase, and lowering glycosphingolipid concentrations in a subject in need thereof respectively comprise administering to the subject a therapeutically effective amount of a compound represented by Structural Formula (I) or a pharmaceutically acceptable salt thereof.
摘要翻译：化合物由结构式（I）表示：或其药学上可接受的盐。药物组合物包含由结构式（I）表示的化合物或其药学上可接受的盐。治疗有需要的受试者的方法包括向受试者施用治疗有效量的由结构式（I）表示的化合物或其药学上可接受的盐。受试者患有2型糖尿病; 肾脏肥大或与糖尿病肾病相关的增生; 泰撒戈谢的或法布里氏病。分别在有需要的受试者中降低血浆TNF-α，降低血糖水平，降低糖化血红蛋白水平，抑制葡萄糖神经酰胺合成酶和降低糖鞘醇浓度的方法包括向受试者施用治疗有效量的由结构式（ I）或其药学上可接受的盐。

9. 发明申请

US20110184021A1 2-Acylaminopropoanol-Type Glucosylceramide Synthase Inhibitors 有权
标题翻译： 2-酰基氨基丙醇型葡萄糖神经酰胺合酶抑制剂
公开(公告)号：US20110184021A1
公开(公告)日：2011-07-28
申请号：US13122135
申请日：2009-10-02
申请人： Craig Siegel , Cecilia M. Bastos , David J. Harris , Angeles Dios , Edward Lee , Richard Silva , Lisa M. Cuff , Mikaela Levine , Cassandra A. Celatka , Thomas H. Jozafiak , Frederic Vinick , Yibin Xiang , John Kane , Junkai Liao
发明人： Craig Siegel , Cecilia M. Bastos , David J. Harris , Angeles Dios , Edward Lee , Richard Silva , Lisa M. Cuff , Mikaela Levine , Cassandra A. Celatka , Thomas H. Jozafiak , Frederic Vinick , Yibin Xiang , John Kane , Junkai Liao
IPC分类号： A61K31/453 , A61K31/40 , A61K31/4025 , A61K31/4439 , A61K31/422 , A61K31/428 , A61P13/12
CPC分类号： A61K31/4025 , C07C271/12 , C07D207/12 , C07D317/60 , C07D319/18 , C07D319/20 , C07D333/16 , C07D407/06 , C07D407/12 , C07D409/04 , C07D413/04 , C07D417/12
摘要： A compound for use in treating polycystic kidney disease is represented by Structural Formula (I): or a pharmaceutically acceptable salt thereof. A pharmaceutical composition comprises a compound represented by Structural Formula (I) or a pharmaceutically acceptable salt thereof. A method of treating polycystic kidney disease in a subject in need thereof comprises administering to the subject a therapeutically effective amount of a compound represented by Structural Formula (I) or a pharmaceutically acceptable salt thereof. Methods of treating in polycystic kidney disease in a subject in need thereof respectively comprise administering to the subject a therapeutically effective amount of a compound represented by Structural Formula (I) or a pharmaceutically acceptable salt thereof.
摘要翻译：用于治疗多囊肾病的化合物由结构式（I）表示：或其药学上可接受的盐。药物组合物包含由结构式（I）表示的化合物或其药学上可接受的盐。在有需要的受试者中治疗多囊肾病的方法包括向受试者施用治疗有效量的由结构式（I）表示的化合物或其药学上可接受的盐。分别在有需要的受试者中治疗多囊肾病的方法包括向受试者施用治疗有效量的由结构式（I）表示的化合物或其药学上可接受的盐。

10. 发明授权

US07734349B2 Osmometric heart monitoring device and methods 有权
标题翻译：渗透心脏监测装置及方法
公开(公告)号：US07734349B2
公开(公告)日：2010-06-08
申请号：US11779403
申请日：2007-07-18
申请人： Allan Charles Shuros , Eric A. Mokelke , Michael John Kane , Jihong Qu
发明人： Allan Charles Shuros , Eric A. Mokelke , Michael John Kane , Jihong Qu
IPC分类号： A61B5/14
CPC分类号： A61N1/3702 , A61B5/0006 , A61B5/02028 , A61B5/076 , A61B5/14539 , A61B5/14546 , A61B5/4869 , A61B2562/02 , A61N1/05 , A61N1/36521 , A61N1/36557 , G01N13/04
摘要： Embodiments of the invention are related to monitoring devices and methods with osmometric sensors, amongst other things. In an embodiment, the invention includes an implantable heart failure monitoring system including an osmometric sensor, the osmometric sensor configured to generate a signal corresponding to the osmotic strength of a bodily fluid, and a controller in communication with the osmometric sensor, the controller configured to receive and process the signal corresponding to the osmotic strength of a bodily fluid. Other aspects and embodiments are provided herein.
摘要翻译：本发明的实施例涉及到具有渗压传感器的监测装置和方法以及其它方面。在一个实施例中，本发明包括可植入心力衰竭监测系统，其包括渗透传感器，所述渗透传感器被配置为产生对应于体液的渗透强度的信号，以及与所述渗透传感器通信的控制器，所述控制器被配置为接收和处理对应于体液渗透强度的信号。本文提供了其它方面和实施例。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式